Description
BLOOD/ BLOOD PRODUCTS
First action · last action
2014-10-01 · 2019-11-04
Transactions
11
First transaction's obligation
$657,058
Base + all options value (sum of deltas)
$4,607,297
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$657,058= $657,058
- Mod P000012015-10-01+$657,058= $1,314,117
- Mod P000022016-10-01+$657,058= $1,971,175
- Mod P000032017-10-01+$657,058= $2,628,234
- Mod P000042018-07-05-$196,374= $2,431,860
- Mod P000052018-10-01+$454,397= $2,886,257
- Mod P000062019-04-17-$144,871= $2,741,386
- Mod P000072019-04-17-$353,793= $2,387,593
- Mod P000082019-04-17-$163,566= $2,224,027
- Mod P000092019-09-19-$171,372= $2,052,655
- Mod P000102019-11-04-$73,592= $1,979,063
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$657,058 | $657,058 | BLOOD/ BLOOD PRODUCTS |
| Mod P00001· EXERCISE AN OPTION | 2015-10-01 | +$657,058 | $1,314,117 | BLOOD/ BLOOD PRODUCTS |
| Mod P00002· EXERCISE AN OPTION | 2016-10-01 | +$657,058 | $1,971,175 | BLOOD/ BLOOD PRODUCTS |
| Mod P00003· EXERCISE AN OPTION | 2017-10-01 | +$657,058 | $2,628,234 | BLOOD/ BLOOD PRODUCTS |
| Mod P00004· CHANGE ORDER | 2018-07-05 | −$196,374 | $2,431,860 | BLOOD/ BLOOD PRODUCTS |
| Mod P00005· EXERCISE AN OPTION | 2018-10-01 | +$454,397 | $2,886,257 | IGF::OT::IGF BLOOD/ BLOOD PRODUCTS |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-04-17 | −$144,871 | $2,741,386 | IGF::OT::IGF BLOOD/ BLOOD PRODUCTS |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-04-17 | −$353,793 | $2,387,593 | IGF::OT::IGF BLOOD/ BLOOD PRODUCTS |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-04-17 | −$163,566 | $2,224,027 | IGF::OT::IGF BLOOD/ BLOOD PRODUCTS |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-09-19 | −$171,372 | $2,052,655 | BLOOD/ BLOOD PRODUCTS |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-11-04 | −$73,592 | $1,979,063 | BLOOD/ BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI G69LHXJ3ABL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226N0550 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,500 | FY2026 |
| 36C25226N0551 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,100 | FY2026 |
| 36C25226N0549 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $170 | FY2026 |
| 36C25226N0548 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,000 | FY2026 |
| 36C25026P0816 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,329 | FY2026 |
| 36C24126N0603 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $1,998,719 | FY2026 |
Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0690 | SINA DRUG LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $188,463 | FY2026 |
| 36C24726N0211 | BOSTON SCIENTIFIC CORP | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $248,982 | FY2026 |
| 36C24726F0100 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $228,396 | FY2026 |
| 36C24726F0053 | EXELAN PHARMACEUTICALS INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $4,765,853 | FY2026 |
| 36C24726F0043 | AMICUS THERAPEUTICS US, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $109,456 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24715C0396_3600_-NONE-_-NONE- · retrieved 2026-09-26.